Based on the systematic review and meta‐analysis with five case‐control studies, no significant association was observed between genetic polymorphisms of NR1I2 and the risk of anti‐tuberculosis drug‐induced hepatotoxicity. This evidence concerns the gene NR1I2 and tuberculosis.